Sativa Group joins the ACI toxicology study

As part of the Sativa Group PLC (AQUIS:SATI) ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the Cannabinoid Industry (ACI) Novel Food consortium and it’s landmark toxicology study, which will augment the submission of it’s own Novel Food application dossier.

The toxicology study will provide safety data that is required for Novel Food dossiers validated by the FSA, and for products to remain available on the market after 31 March 2021.

Sativa and Stillcanna’s team of scientists and quality/compliance professionals in the UK and Poland have worked with the ACI to ensure it’s CBD products meet their rigorous quality management criteria.

As part of this regulatory process, the raw CBD ingredients and final products are tested by a leading third-party laboratory, and cultivation, extraction and manufacturing processes and standards are scrutinised, to ensure that Sativa is meeting safety and regulatory standards from seed through to shelf.

The Company is submitting its own novel food application for it’s portfolio of products and brands, and on behalf of White Label customers.   

Henry Lees-Buckley, Chief Executive Office of Sativa, said: “At Sativa, producing the highest quality and compliant products is our number one objective! We welcome the FSA Novel Foods accreditation process and are very pleased to be associated with the ACI In our compliance efforts”.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Sativa Group

    More articles like this

    Sativa Group

    Goodbody Botanicals stores remain open during COVID-19

    At George Botanicals, Goodbody Botanicals and Goodbody Wellness, our customer wellbeing is always at the forefront of what we do.  We’ve been monitoring the development of the COVID-19 situation and have been closely following the advice of

    Sativa Group

    Using CBD in your every day life

    People often ask us here at Goodbody Botanicals, “How should I take CBD?” and we will just say whatever feels best for you. For some people, they will use the oil drops as a tincture, but others may

    Sativa Group

    The Rise of CBD

    CBD stands for cannabidiol, an ingredient made from hemp plant extract – and public interest is growing fast. It’s estimated that the number of British consumers using CBD products has quadrupled over a two-year period to

    Sativa Group

    Sativa Group How distributor alignments are now paying off

    Sativa Group plc (NEX:SATI) CEO Henry Lees-Buckley chats with DirectorsTalk about GoodBody Botanicals being awarded the WH Smith travel business. Henry explains why this is exciting for the company, how its alignment with distributors is paying off, why

    Sativa Group

    How much CBD should you take?

    It’s hard to tell with CBD just how much will work for you, and we’re going to explore ways you can ease into finding what works best for you, as well as why CBD is so

    Sativa Group

    Sativa Group welcomes Food Standard Authority guidelines

    Sativa Group (NEX:SATI) today noted the recent announcement by the Food Standards Agency (“FSA”) concerning the safe use of CBD products and the timetable for Novel Food authorisation.  It welcomes the clarity of a regulatory framework

    Sativa Group

    A focus on the rise of cannabidiol (CBD)

    George Thomas, Managing Director of Goodbody Botanicals, part of Sativa Group Plc, turn our thoughts towards the undoubted rise of cannabidiol (CBD) Rewind two or three years and CBD wasn’t even on the radar of the fast-moving consumer

    Sativa Group

    Sativa Group Significant progress in 2019

    Sativa Group (NEX:SATI) has today provided a trading update for the year ended 31 December 2019, along with a general business update.  2019 was a year of significant progress for the Group.  The strategic focus and

    Sativa Group

    The most Googled question in the UK… what is CBD?

    What is CBD? Is the single most asked question on Google UK with 2,900 searches a month, it’s been revealed. The questions show there is still confusion about what CBD actually is, if it works and

    Sativa Group

    ‘CBD oil helps me cope with my anxiety’

    Susannah Bell along with other users of cannabidiol, better known as CBD, say it has medicinal benefits and helps her with anxiety, but those who sell it are not allowed to make any medical claims. CBD